BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31866182)

  • 1. Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.
    Freyer DR; Brock PR; Chang KW; Dupuis LL; Epelman S; Knight K; Mills D; Phillips R; Potter E; Risby D; Simpkin P; Sullivan M; Cabral S; Robinson PD; Sung L
    Lancet Child Adolesc Health; 2020 Feb; 4(2):141-150. PubMed ID: 31866182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
    Freyer DR; Brock P; Knight K; Reaman G; Cabral S; Robinson PD; Sung L
    Lancet Child Adolesc Health; 2019 Aug; 3(8):578-584. PubMed ID: 31160205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.
    Freyer DR; Chen L; Krailo MD; Knight K; Villaluna D; Bliss B; Pollock BH; Ramdas J; Lange B; Van Hoff D; VanSoelen ML; Wiernikowski J; Neuwelt EA; Sung L
    Lancet Oncol; 2017 Jan; 18(1):63-74. PubMed ID: 27914822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey.
    Orgel E; Freyer DR; Ullrich NJ; Hardy KK; Thomas SM; Dvorak CC; Esbenshade AJ
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28647. PubMed ID: 32886425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.
    Viglietta V; Shi F; Hu QY; Ren Y; Keilty J; Wolff H; McCarthy R; Kropp J; Weber P; Soglia J
    Invest New Drugs; 2020 Oct; 38(5):1463-1471. PubMed ID: 32157599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
    Brock PR; Maibach R; Childs M; Rajput K; Roebuck D; Sullivan MJ; Laithier V; Ronghe M; Dall'Igna P; Hiyama E; Brichard B; Skeen J; Mateos ME; Capra M; Rangaswami AA; Ansari M; Rechnitzer C; Veal GJ; Covezzoli A; Brugières L; Perilongo G; Czauderna P; Morland B; Neuwelt EA
    N Engl J Med; 2018 Jun; 378(25):2376-2385. PubMed ID: 29924955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cisplatin-induced hearing-loss by sodium thiosulfate in medulloblastoma.
    Harao T; Yamada A; Kinoshita M; Kamimura S; Moritake H
    Pediatr Int; 2020 Oct; 62(10):1204-1206. PubMed ID: 32989850
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
    Rolland V; Meyer F; Guitton MJ; Bussières R; Philippon D; Bairati I; Leclerc M; Côté M
    J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):4. PubMed ID: 30651130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010885. PubMed ID: 29975402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010885. PubMed ID: 31961948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platinum-induced hearing loss after treatment for childhood cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoblastoma, cisplatin, and ototoxicity: good news on deaf ears.
    Sullivan MJ
    Cancer; 2009 Dec; 115(24):5623-6. PubMed ID: 19813276
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective effects of sodium thiosulfate for cisplatin-mediated ototoxicity in patients with head and neck cancer.
    Ishikawa E; Sugimoto H; Hatano M; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Murono S; Ito M; Yoshizaki T
    Acta Otolaryngol; 2015 Sep; 135(9):919-24. PubMed ID: 25861690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ototoxicity in patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin and sodium thiosulfate.
    Womack AM; Hayes-Jordan A; Pratihar R; Barringer DA; Hall JH; Gidley PW; Lewin JS
    Ear Hear; 2014; 35(6):e243-7. PubMed ID: 25127324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of cisplatin-induced ototoxicity in adults: A systematic review.
    Correa-Morales JE; Giraldo-Moreno S; Mantilla-Manosalva N; Cuellar-Valencia L; Borja-Montes OF; Bedoya-Muñoz LJ; Iriarte-Aristizábal MF; Quintero-Muñoz E; Zuluaga-Liberato AM
    Clin Otolaryngol; 2024 Jan; 49(1):1-15. PubMed ID: 37818931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.